Skip to content
Disclosery

EXANE DERIVATIVES: DIS position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on DIS, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 16,945 DIS shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 16,945 shares
    Change vs previous 13F -3,017 shares

    0.92% of the 13F portfolio, value $1,599,439.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 19,962 shares
    Change vs previous 13F -906 shares

    0.77% of the 13F portfolio, value $2,738,007.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 20,868 shares
    Change vs previous 13F +1,913 shares

    0.79% of the 13F portfolio, value $3,232,349.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 18,955 shares
    Change vs previous 13F -4,670 shares

    0.8% of the 13F portfolio, value $3,206,744.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 23,625 shares
    Change vs previous 13F +332 shares

    1.02% of the 13F portfolio, value $4,338,828.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 23,293 shares
    Change vs previous 13F -610 shares

    1.29% of the 13F portfolio, value $4,298,223.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 23,903 shares
    Change vs previous 13F -8,976 shares

    1.31% of the 13F portfolio, value $4,330,937.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 32,879 shares
    Change vs previous 13F not available

    1.33% of the 13F portfolio, value $4,079,736.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).